# RNN 1st Gen Model Perrigo Company Pharmaceutical preparations
at 14-nov-2019
PRGO
Model's trade recommendations 2.44% Return for period
27.20% Annual return
$10.75B Market Cap
β 0.77
PRGO
Model (following trade recommendations)PRGO
Underlying stockS&P 500
Index- 0.76 (1.00%) Div (Yield)
- BUY Analysts consensus recommendation
Perrigo Company plc develops, manufactures and distributes healthcare products. The company operates primarily in four segments: Consumer Healthcare, Nutritionals, Rx Pharmaceutical and Active Pharmaceutical Ingredients. It also provides animal health products. The company operates primarily in the United States, the United Kingdom, Mexico, Israel, Australia, Canada, China and Latin America. Perrigo Company plc formerly known as Perrigo Company is headquartered in Ireland.
Industry sector: Medical
Sector classification: Pharmaceutical preparations
Deep Learning based analysis and prediction model for Perrigo Company (PRGO) stock is a 1st Generation Non-linear Autoregresive with exogenous variable(s) (NARX) model based on the Recurrent Neural Network architecture.
Model is in the production pipeline since Sept. 30, 2015.
Market data for PRGO model training are being downloaded from the Quandl premium datasets on a daily basis.
Model is being retrained on a daily basis.
| Float | 131M |
| P/E | 15.45 |
| Shares Outstanding | 141M |
| % Held by Insiders | 6.90% |
| % Held by Institutions | 79.12% |
| EPS (last reported FY) | $4.93 |
| EPS (last reported Q) | $1.28 |
| EPS, estimated (last reported Q) | $1.24 |
| Total revenues | $5 B |
| Net income | $0 B |